home / stock / myndf / myndf quote
Last: | $0.0125 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0125 |
Close: | $0.0125 |
High: | $0.0125 |
Low: | $0.0125 |
Volume: | 100 |
Last Trade Date Time: | 07/01/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0125 | $0.0125 | $0.0125 | $0.0125 | $0.0125 | 100 | 07-01-2024 |
$0.03 | $0.03 | $0.03 | $0.03 | $0.03 | 17,110 | 06-28-2024 |
$0.0249 | $0.0249 | $0.0249 | $0.0249 | $0.0249 | 9,995 | 05-02-2024 |
$0.0212 | $0.0212 | $0.0212 | $0.0212 | $0.0212 | 2,405 | 05-01-2024 |
$0.0227 | $0.0227 | $0.0227 | $0.0227 | $0.0227 | 1,000 | 03-15-2024 |
$0.0196 | $0.0196 | $0.0196 | $0.0196 | $0.0196 | 5,000 | 03-08-2024 |
$0.01515 | $0.01515 | $0.01515 | $0.01515 | $0.01515 | 400 | 03-05-2024 |
$0.0192 | $0.0193 | $0.0192 | $0.0193 | $0.0192 | 2,700 | 03-04-2024 |
$0.01705 | $0.01705 | $0.01705 | $0.01705 | $0.01705 | 2,000 | 02-27-2024 |
$0.0257 | $0.0257 | $0.0257 | $0.0257 | $0.0257 | 100 | 02-15-2024 |
$0.0267 | $0.0267 | $0.0267 | $0.0267 | $0.0267 | 1,500 | 02-09-2024 |
$0.027 | $0.027 | $0.027 | $0.027 | $0.027 | 1,500 | 02-05-2024 |
$0.02 | $0.02045 | $0.02 | $0.02045 | $0.02 | 10,600 | 01-23-2024 |
$0.03 | $0.03 | $0.03 | $0.03 | $0.03 | 600 | 01-02-2024 |
$0.0312 | $0.0312 | $0.0312 | $0.0312 | $0.0312 | 10,000 | 12-27-2023 |
$0.02415 | $0.02415 | $0.02415 | $0.02415 | $0.02415 | 100 | 12-20-2023 |
$0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 29,000 | 10-20-2023 |
$0.0171 | $0.0171 | $0.0171 | $0.0171 | $0.0171 | 10,000 | 07-28-2023 |
$0.04 | $0.04 | $0.04 | $0.04 | $0.04 | 30,000 | 07-21-2023 |
$0.026 | $0.026 | $0.026 | $0.026 | $0.026 | 14,000 | 06-26-2023 |
News, Short Squeeze, Breakout and More Instantly...
Vancouver, British Columbia--(Newsfile Corp. - January 30, 2024) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) (" MYND " or the " Company ") The Company is pleased to welcome Ms. Laurie Bakke who was recently appointed to MYND's Board. Ms. Bakke joins as an independent non-executive director,...
Vancouver, British Columbia--(Newsfile Corp. - December 5, 2023) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) (" MYND " or the " Company "), a pioneering biopharmaceutical research and development company committed to advancing treatments for patients coping with chronic and a...
Vancouver, British Columbia--(Newsfile Corp. - December 4, 2023) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) (" MYND " or the " Company "), We are delighted to announce the appointment of Mynd Life Sciences current CEO and Director, the Hon. Dr. Lyle Oberg, E.C.A., as the Boa...